Insmed Inc. News
Cramer's Mad Money Recap 12/1: Disney, PayPal, Citigroup
Jim Cramer says there are stock bargains hiding in plain sight. Don't miss this buying opportunity.
Insmed Drug for Chronic Lung Ailment Meets Main Endpoint in Trial
Insmed's shares rose after the biotech reported that a candidate drug to treat bronchiectasis, a chronic lung condition, met its primary endpoint in a Phase II trial.
Trading Roku Stock as Downgrades Sap Its Run to New Highs
Roku was hit with a pair of downgrades on Wednesday
North Korea Gives Wall Street Rude Awakening After Labor Day Break
Stocks finish lower as North Korea threat returns.
Dow Tanks, Fear Gauge Spikes as United Tech Slumps, North Korea Rattles Nerves
Stocks are lower as North Korea threat returns. Here's where stocks are trading by the afternoon session.
North Korea Threat Roars Back Into Focus and Wall Street Retreats
Stocks are lower as North Korea threat returns. Here's where stocks are trading at the market open.
Stock Futures Decline Amid Rising North Korea Tensions
Stock futures are lower as North Korea threat returns. Here's where stocks are trading ahead of the market open.
Health Sector Down As Report of Industry Price Collusion Surfaces
The healthcare sector was dragged down by reports of price collusion and worse-than-expected third-quarter profits.
SEC Slaps Biotech Hedge Fund for Short-Selling Violations
On 17 occasions, RA Capital bought shares in biotech company financings after having sold short shares of the same company when it was supposed to be restricted from doing so.
Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks
A month after Fed Chair Janet Yellen's comments, ETFs covering both groups are pushing towards new highs on strong fundamental backdrops.
UnitedHealth Group Stock Edges Lower On Muted 2023 Profit Forecast
UnitedHealth, a Dow component, will host it annual investor event later today in New York.
Roku Stock Slides As KeyBanc Cuts Rating to 'Sector Weight' On Ad Weakness
Roku's eroding market share, and its need for new investment, will pressure near-term profits, according to KeyBanc analyst Justin Patterson.
Tesla Sentiment, Fundamentals Affected By Musk's Twitter Purchase - Morgan Stanley Survey
“Our investor survey reinforces our views that Elon Musk's recent involvement with Twitter has contributed to negative sentiment momentum in Tesla shares," said Morgan Stanley analyst Adam Jonas.
'Un-carrier' T-Mobile Makes a Very Verizon, AT&T 'Carrier' Move
Mobile carrier companies are always eager to increase revenue through fees customers pay and to outflank their competition with deals.